Sunday 11 October 2026 Export all UHT data to Excel Powerpack

Universal Health Realty Income Trust

UHT Real Estate Reit Healthcare Facilities

Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 30.3%, free cash flow fell 69.3% and total debt rose 2.73%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for ten.

37.57 0.03 +0.08%

Follow UHT

Alert me

Market cap: $521.8M
P/E: 27.0×
Fwd P/E: 31.2×
Dividend yield: 7.96%
F-score: 4/9
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 8.01%

Capital & Financial Ratios $m

Market Cap 521.75

Revenue 99.29

Net Income 19.27

Free Cash Flow 29.90

Net Debt 376.88

Current Ratio 5.54

Debt/Equity 2.67

P/E ratio 27.03

Fwd P/E 31.20

P/S ratio 5.24

P/B ratio 3.61

Past 5Y EPS Growth (2.07%)

This Y EPS Growth 13.67%

Next Y EPS Growth 9.49%

Next Y revenue growth 0.31%

Next 5Y EPS Growth 9.40%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 19.68%

10-year low 10-year high

P/S against its own 10 years 3.14%

10-year low 10-year high

P/B against its own 10 years 39.36%

10-year low 10-year high

EV/Sales against its own 10 years 4.65%

10-year low 10-year high

EV/FCF against its own 10 years 32.98%

10-year low 10-year high

Dividends

Payout Ratio 2.15

Annual Dividend Rate 2.99

Annual Dividend Yield 7.96%

	total	individual payouts
2026	2.25	0.75 0.75 0.75
2025	2.96	0.74 0.74 0.74 0.75
2024	2.92	0.73 0.73 0.73 0.74
2023	2.88	0.72 0.72 0.72 0.73
2022	2.84	0.71 0.71 0.71 0.72
2021	2.80	0.70 0.70 0.70 0.71
2020	2.76	0.69 0.69 0.69 0.70
2019	2.72	0.68 0.68 0.68 0.69
2018	2.68	0.67 0.67 0.67 0.68
2017	2.64	0.66 0.66 0.66 0.67
2016	2.60	0.65 0.65 0.65 0.66

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	8	7	7	7
Receivables	83	83	82	82
Inventory	—	—	—	—
Other	—	—	—	—
	91	90	89	89

	2023	2024	2025	Q'26
Payables	—	—	—	—
ST’ Debt	—	—	—	—
Other	—	—	—	—
	14	11	15	16

Compound Annual Growth %

	10y	5y	3y
Sales	4.49%	4.92%	3.06%
Cash Flow	2.55%	2.12%	1.60%
Earnings	(2.92%)	(1.97%)	(5.85%)
Book Value	(2.44%)	(0.85%)	(12.71%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	25	25	—	—	—
’25	25	25	25	24	99
’24	25	25	24	25	99
’23	23	24	24	24	96
’22	22	22	22	24	91
’21	21	21	21	21	84
’20	19	19	20	20	78

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	12	12	—	—	—
’25	12	14	10	14	49
’24	12	12	10	13	47
’23	10	12	10	10	43
’22	12	13	10	12	47
’21	11	14	11	12	48
’20	10	13	10	11	44

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	8	4	—	—	—
’25	10	12	9	10	40
’24	8	11	9	9	38
’23	9	5	(1)	15	27
’22	(5)	5	4	20	24
’21	4	0	7	9	20
’20	5	10	4	1	20

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.36	0.43	—	—	—
’25	0.34	0.32	0.29	0.31	1.27
’24	0.38	0.38	0.29	0.34	1.39
’23	0.32	0.25	0.28	0.26	1.11
’22	0.39	0.38	0.35	0.41	1.53
’21	0.41	0.48	0.39	6.65	7.92
’20	0.33	0.34	0.38	0.36	1.41

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	45.42	59.11	53.00	59.38	52.25	55.01	40.92	37.00	32.27	34.56	Analyst estimates 2026–2028 Powerpack
	High	66.00	84.90	76.97	123.84	132.41	75.61	61.32	57.52	47.30	43.00
People
People	Employees	—	—	—	—	—	—	—	—	—	—
	Revenue/emp, $m	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income, $m
Income, $m	Revenue	67	72	76	77	78	84	91	96	99	99
	Gross margin, %	95.14	95.06	95.01	94.85	94.69	94.77	94.38	94.43	94.46	94.36
	EBT	13	43	22	17	18	107	20	14	18	16
	EBT margin, %	19.02	59.72	29.43	22.25	22.74	127.53	21.97	14.85	18.13	16.04
	Net income	17	46	24	19	19	109	21	15	19	18
	Depreciation	23	25	25	26	26	28	27	28	28	29
Per share, $
Per share, $	Revenue	4.98	5.31	5.55	5.62	5.68	6.12	6.58	6.93	7.17	7.18
	Earnings	1.28	3.35	1.76	1.38	1.42	7.94	1.53	1.12	1.39	1.27
	Cash flow	3.03	3.38	3.13	3.11	3.22	3.47	3.40	3.11	3.40	3.55
	Capex	(0.83)	(1.12)	(0.60)	(0.90)	(1.75)	(1.99)	(1.63)	(1.13)	(0.66)	(0.64)
	Free cash flow	2.19	2.25	2.53	2.21	1.47	1.48	1.77	1.98	2.74	2.91
	Book value	14.21	15.45	14.47	13.23	11.57	17.11	16.64	14.58	13.01	11.03
	Shares, m	13	14	14	14	14	14	14	14	14	14
Valuation, ×
Valuation, ×	P/E	51.25	22.02	34.87	84.43	45.58	7.49	31.42	39.56	26.77	30.63
	P/S	13.17	13.89	11.05	20.89	11.32	9.72	7.30	6.33	5.19	5.46
	P/B	4.62	4.77	4.24	8.87	5.55	3.48	2.89	3.01	2.86	3.56
	EV/Sales	17.81	17.39	14.41	24.35	15.03	13.36	11.00	10.01	8.83	9.17
	EV/FCF	40.47	40.99	31.69	61.95	58.03	55.07	41.00	34.97	23.12	22.60
Cash, $m
Cash, $m	Operating cash flow	41	46	43	43	44	48	47	43	47	49
	Capex	(11)	(15)	(8)	(12)	(24)	(27)	(22)	(16)	(9)	(9)
	Free cash flow	30	31	35	30	20	20	24	27	38	40
Balance, $m
Balance, $m	Working capital	(1)	0	3	3	(4)	92	92	78	79	74
	Total debt	316	256	261	274	295	329	343	359	368	375
	Net debt	312	253	256	268	289	306	335	351	361	368
	Shareholders’ equity	191	211	199	182	159	235	229	201	180	152
Returns, %
Returns, %	ROA	3.50	8.99	4.97	3.90	3.96	19.99	3.50	2.56	3.27	3.07
	ROIC	2.75	3.24	3.67	3.58	3.62	3.33	3.40	3.55	4.25	4.18
	ROE	8.91	22.71	11.83	9.97	11.41	55.37	9.09	7.16	10.11	10.61

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SBRA Sabra Healthcare REIT, Inc.	$4.8B	72.9×	27.3×	+24.70% (above 0%: growing)	n/m	−666.09% (below 0%: shrinking)	100.00%	(13.59%)	Compare
NHI National Health Investors, Inc.	$3.2B	18.7×	20.2×	+33.81% (above 0%: growing)	+45.57% (above 0%: growing)	+2,585.45% (above 0%: growing)	72.18%	41.09%	Compare
LTC LTC Properties, Inc.	$2.3B	15.5×	18.8×	+64.11% (above 0%: growing)	+72.73% (above 0%: growing)	−213.92% (below 0%: shrinking)	100.00%	31.24%	Compare
MPT Medical Properties Trust, Inc.	$1.9B	— (loss-making)	39.5×	+7.87% (above 0%: growing)	n/m	−15.15% (below 0%: shrinking)	95.68%	3.31%	Compare
DHC Diversified Healthcare Trust	$1.8B	— (loss-making)	8.4×	−4.53% (below 0%: shrinking)	n/m	−93.96% (below 0%: shrinking)	23.11%	(0.14%)	Compare
STRW Strawberry Fields REIT, Inc.	$716.3M	19.9×	19.3×	+5.78% (above 0%: growing)	0.00%	+55.53% (above 0%: growing)	89.67%	53.67%	Compare
UHT Universal Health Realty Income Trust	$521.8M	27.0×	31.2×	+0.49% (above 0%: growing)	+30.30% (above 0%: growing)	−69.28% (below 0%: shrinking)	94.29%	36.83%
XRN Chiron Real Estate Inc.	$494.3M	9.0×	— (loss-making)	+4.68% (above 0%: growing)	n/m	−18.02% (below 0%: shrinking)	100.00%	23.19%	Compare
CHCT Community Healthcare Trust Incorporated	$392.0M	20.3×	36.8×	+7.35% (above 0%: growing)	n/m	+35.09% (above 0%: growing)	81.22%	31.17%	Compare
Median of peers	$1.9B	19.3×	20.2×	+7.61%	+45.57%	−16.58%	92.68%	27.18%

All 16 Reit Healthcare Facilities stocks →

Universal Health Realty Income Trust (UHT) key facts

Concern: Net income was $17.6 million, or $1.27 per share (basic), a net margin of 17.8%.
Universal Health Realty Income Trust (UHT) is a Reit Healthcare Facilities company in the Real Estate sector, listed on the New York Stock Exchange.
Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024.
As of October 9, 2026, UHT traded at $37.57, a market capitalization of $521.8 million.
At that price the stock trades at 27.0× trailing-twelve-month earnings and 5.2× sales; its P/E is higher than 20% of its own readings over the past ten years.
Universal Health Realty Income Trust pays an annual dividend of $2.99 per share, a yield of 7.96%.
Return on equity was 10.6% and debt-to-equity 2.67.
Its Piotroski F-score is 4 out of 9 for fiscal 2025.